Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies

Stroke; a Journal of Cerebral Circulation
P M FordS E Ford

Abstract

Lupus anticoagulant and antiphospholipid antibodies are associated with thromboembolic phenomena in individuals both with and without systemic lupus erythematosus. A 32-year-old woman (the index case) with lupus anticoagulant, multiple cerebrovascular events, and a family history of premature stroke raised the possibility of a familial diathesis. Histories or interviews, examinations, and blood tests were obtained for 23 members of four generations of her family. Four individuals had suffered strokes and three more had suffered neurologic symptoms. Two living individuals who had suffered strokes, two individuals with neurologic symptoms, and five asymptomatic individuals had antiphospholipid activity in their blood. In addition, a cousin of the index case was found to have systemic lupus erythematosus and antiphospholipid activity. Elevated concentrations of von Willebrand factor antigen were found associated with some positive lupus anticoagulant assays, the highest concentrations in the two individuals with stroke. The characteristic presentation of the index case and her good response to treatment suggests that further studies of families in whom antiphospholipid antibodies may represent a risk factor for stroke is worthwhile.

References

Sep 1, 1978·British Journal of Haematology·T ExnerH Kronenberg
Jan 1, 1989·Annals of the Rheumatic Diseases·E N Harris
Apr 1, 1987·Arthritis and Rheumatism·M D Lockshin
Oct 1, 1987·Annals of the Rheumatic Diseases·M A ByronS A Cederholm-Williams
Nov 1, 1987·British Journal of Haematology·I J MackieS J Machin
Feb 1, 1985·British Journal of Haematology·E N HarrisG R Hughes
Apr 26, 1973·The New England Journal of Medicine·UNKNOWN Collaborative Group for the Study of Stroke in Young Women
Apr 1, 1984·British Journal of Obstetrics and Gynaecology·W F LubbeG C Liggins
Feb 1, 1980·Annals of Internal Medicine·J R MuehS I Rapaport
May 1, 1980·British Journal of Haematology·T ExnerK A Rickard

❮ Previous
Next ❯

Citations

Mar 1, 1993·Italian Journal of Neurological Sciences·S SeveriA Miele
Nov 1, 1994·Clinical Neurology and Neurosurgery·V FetoniF Girotti
Apr 1, 1995·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·S E Ford, P M Ford
Jul 27, 1999·Thrombosis Research·A CantalapiedraJ M Cesar
Sep 12, 2003·Current Rheumatology Reports·Bahram Namjou
Sep 1, 2015·Autoimmunity Reviews·Lucas L van den HoogenRonald H W M Derksen
Aug 8, 2009·British Journal of Haematology·Jesús Castro-MarreroJosep Ordi-Ros
Nov 1, 1995·The American Journal of Medicine·S N GoldbergT P Greco
Nov 17, 2012·Lupus·V RavindranG Elias
Aug 23, 2007·Lupus·Al Sestak, K M O'Neil
Oct 1, 1996·Lupus·W A Wilson, A E Gharavi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.